Plasminogen-activator Inhibitor 1 (PAI-1) participates in the occurrence and development of this state and is elevated in patients with type 2 diabetes, impaired glucose tolerance, and obesity. Here, SERPINE1 is linked to obesity due to melanocortin 4 receptor deficiency.